Impact of Musical Therapeutic Intervention on Depression in Dementia Patients and Caregiver Burden (NCT07069530) | Clinical Trial Compass
CompletedNot Applicable
Impact of Musical Therapeutic Intervention on Depression in Dementia Patients and Caregiver Burden
United States25 participantsStarted 2022-02-01
Plain-language summary
This single-site interventional study evaluated the effects of receptive live music therapy on depression in patients with dementia and caregiver burden at the AMAVIDA Memory Care Unit in Fort Myers, Florida. Over two weeks, participants attended six 30-minute live piano performances using a fixed setlist delivered one hour before dinner. Pre- and post-intervention assessments included the Geriatric Depression Scale (GDS) for patients and the Caregiver Burden Scale in End-of-Life Care (CBS-EOLC) for staff caregivers. Data were analyzed using paired-sample t-tests to compare depression and burden scores before and after the music intervention.
Who can participate
Age range
25 Years – 90 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Resident participants must be aged 60 or older.
* Residents must have a documented diagnosis of Alzheimer's disease or related dementia.
* Residents must have completed a Mini-Mental State Examination (MMSE) with a score of ≥17.
* Caregiver participants must be aged 25 or older.
* Caregivers must have at least one year of experience working in the memory care unit.
Exclusion Criteria:
* Residents with MMSE scores \<17 indicating severe cognitive impairment.
* Residents unable to provide coherent verbal responses.
* Participants (residents or caregivers) who decline to provide informed consent.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Change in Geriatric Depression Scale (GDS) Score Among Residents
Timeframe: Within 2 weeks (pre- and post-intervention)